Dynamics Group AG Publishes Research Report on Senetek

NAPA, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Senetek PLC (OTCBulletinBoard: SNKTY) , a life sciences company engaged in the development of technologies that target the science of healthy aging, announced today that Dynamics Group AG, specialists in the fields of strategic development, communication management and research with offices in Zurich, Bern and Geneva has published a Research Report on the Company.

The Research Report, available in the "Investors" section of the Company's website, http://www.senetekplc.com, is a comprehensive analysis aimed at educating and informing investors and potential investors. The document was prepared by the Dynamics Group AG as a non-binding opinion and was compiled to provide background information. The contents of the report do not represent an assurance or guarantee by Dynamics Group AG.

About Senetek, PLC

Senetek PLC (OTCBB: SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.